Home > Financial Ratios > GLAND PHARMA
AD     Remove this Ad

GLAND PHARMA Last 5 Year EV/Net Sales History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/Net Sales(x) 4.265.094.7311.5010.84

What is the latest EV/Net Sales ratio of GLAND PHARMA ?

The latest EV/Net Sales ratio of GLAND PHARMA is 4.26 based on Mar2025 Consolidated results.
Year EV/Net Sales
Mar20254.26
Mar20245.09
Mar20234.73
Mar202211.50
Mar202110.84

How is EV/Net Sales of GLAND PHARMA Trending?

Years EV/Net Sales % Change
Mar2025 4.26
-16.31
Mar2024 5.09
7.61
Mar2023 4.73
-58.87
Mar2022 11.5
6.09
Mar2021 10.84 -

Other Financial Ratios of GLAND PHARMA


Compare EV/Net Sales ratio of peers of GLAND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAND PHARMA ₹30,770.6 Cr 0.5% 9.3% 20.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹428,185.0 Cr 3% 9.5% 3.1% Stock Analytics
DIVIS LABORATORIES ₹171,766.0 Cr 1.7% 3.1% 5.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹148,923.0 Cr 4.7% 11.7% 41.1% Stock Analytics
DR REDDYS LABORATORIES ₹110,081.0 Cr 2.1% 6.7% 11.6% Stock Analytics
CIPLA ₹109,680.0 Cr 1.3% 1.3% -9.4% Stock Analytics


GLAND PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLAND PHARMA

0.5%

9.3%

20.1%

SENSEX

-0.3%

-0.1%

8.3%


You may also like the below Video Courses